143 related articles for article (PubMed ID: 8158123)
1. In vivo evidence that nonneuronal beta-adrenoceptors as well as dopamine receptors contribute to cyclic AMP efflux in rat striatum.
Suyama K; Dykstra KH; Masana MI; Manji HK; Potter WZ
J Neurochem; 1994 May; 62(5):1734-40. PubMed ID: 8158123
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D1 receptor stimulation of cyclic AMP accumulation in COS-1 cells.
Steffey ME; Snyder GL; Barrett RW; Fink JS; Ackerman M; Adams P; Bhatt R; Gomez E; MacKenzie RG
Eur J Pharmacol; 1991 Aug; 207(4):311-7. PubMed ID: 1664335
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain.
Kelly E; Nahorski SR
Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):508-12. PubMed ID: 2441268
[TBL] [Abstract][Full Text] [Related]
4. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
5. Independent in vitro regulation by the D-2 dopamine receptor of dopamine-stimulated efflux of cyclic AMP and K+-stimulated release of acetylcholine from rat neostriatum.
Stoof JC; Kebabian JW
Brain Res; 1982 Nov; 250(2):263-70. PubMed ID: 6293642
[TBL] [Abstract][Full Text] [Related]
6. Receptor-linked cyclic AMP systems in rat neostriatum: differential localization revealed by kainic acid injection.
Minneman KP; Quik M; Emson PC
Brain Res; 1978 Aug; 151(3):507-21. PubMed ID: 27287
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
[TBL] [Abstract][Full Text] [Related]
8. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour.
Ikeda H; Moribe S; Sato M; Kotani A; Koshikawa N; Cools AR
Eur J Pharmacol; 2007 Jan; 554(2-3):175-82. PubMed ID: 17113067
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of dopamine agonist-induced phosphoinositide hydrolysis by concomitant stimulation of cyclic AMP formation in brain slices.
Undie AS; Friedman E
J Neurochem; 1994 Jul; 63(1):222-30. PubMed ID: 7911510
[TBL] [Abstract][Full Text] [Related]
10. Striatal dopamine release in vitro: a beta-adrenoceptor-regulated response not mediated through cyclic AMP.
Reisine T; Chesselet MF; Glowinski J
J Neurochem; 1982 Oct; 39(4):976-81. PubMed ID: 6181195
[TBL] [Abstract][Full Text] [Related]
11. Characterization of dopamine and beta-adrenergic receptors linked to cyclic AMP formation in intact cells of the clone D384 derived from a human astrocytoma.
Balmforth AJ; Yasunari K; Vaughan PF; Ball SG
J Neurochem; 1988 Nov; 51(5):1510-5. PubMed ID: 2459312
[TBL] [Abstract][Full Text] [Related]
12. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum.
Stoof JC; Kebabian JW
Nature; 1981 Nov; 294(5839):366-8. PubMed ID: 6273735
[No Abstract] [Full Text] [Related]
13. mu-Opioid receptor-regulated adenylate cyclase activity in primary cultures of rat striatal neurons upon chronic morphine exposure.
Van Vliet BJ; De Vries TJ; Wardeh G; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1991 Oct; 208(2):105-11. PubMed ID: 1666051
[TBL] [Abstract][Full Text] [Related]
14. Persistence of beta-adrenergic receptors in rat striatum following kainic acid administration.
Zahniser NR; Minneman KP; Molinoff PB
Brain Res; 1979 Dec; 178(2-3):589-95. PubMed ID: 228797
[No Abstract] [Full Text] [Related]
15. M-1 and M-2 muscarinic receptor-mediated inhibition of dopamine-sensitive adenylate cyclase in rat neostriatum: a permissive role for D-2 dopamine receptors.
Schoffelmeer AN; Hogenboom F; Mulder AH
J Pharmacol Exp Ther; 1988 May; 245(2):658-63. PubMed ID: 2452877
[TBL] [Abstract][Full Text] [Related]
16. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
Walters DE; Howard SG
Eur J Pharmacol; 1990 Aug; 184(2-3):257-64. PubMed ID: 2150376
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of dopamine D-1-mediated cyclic AMP formation by dopamine D-2, muscarinic cholinergic, and opiate receptor stimulation in rat striatal slices.
Kelly E; Nahorski SR
J Neurochem; 1986 Nov; 47(5):1512-6. PubMed ID: 2428936
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain.
Undie AS; Weinstock J; Sarau HM; Friedman E
J Neurochem; 1994 May; 62(5):2045-8. PubMed ID: 7908949
[TBL] [Abstract][Full Text] [Related]
19. Low doses of l-sulpiride down-regulate striatal and cortical dopamine receptors and beta-adrenoceptors.
Sigala S; Rizzonelli P; Zanelli E; Forgione A; Missale C; Spano P
Eur J Pharmacol; 1991 Jun; 199(2):247-53. PubMed ID: 1683290
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain.
Undie AS; Friedman E
J Pharmacol Exp Ther; 1990 Jun; 253(3):987-92. PubMed ID: 1972756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
